Healy GmbH

Healy GmbH specializes in two primary categories of medical devices: transcutaneous neuromuscular electrical stimulation (TENS/NMES) systems for physical therapy, which help stimulate muscles for rehabilitation purposes, and multi-purpose blood storage solutions designed to preserve and maintain blood compatibility during clinical storage. These devices address distinct medical needs, ranging from musculoskeletal recovery to blood preservation in healthcare settings.

Healy GmbH is based in the United States. While the company’s location influences its regulatory jurisdiction, it is important to note that individual devices must meet the specific requirements of the regulatory bodies overseeing their use, such as the FDA in the U.S. The classification and compliance of each device depend on its intended purpose and risk level, not the company’s headquarters alone.

Healy GmbH’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices in the U.S., ensuring transparency and traceability for regulatory and clinical purposes. Listing in this database is a key step for devices classified under the FDA’s framework, particularly for Class II devices, which require additional scrutiny due to their moderate risk.

Healy GmbH’s devices are classified as Class II under regulatory frameworks. This classification is determined based on the level of risk associated with the device’s intended use. Class II devices generally pose moderate risk and require special controls in addition to general controls to ensure their safety and effectiveness, such as performance standards or post-market surveillance.